During the past decade, OHSU Knight Cancer Institute conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 77 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 30 clinical trials were completed. i.e. 38% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OHSU Knight Cancer Institute" #1 sponsor was "OHSU Knight Cancer Institute" with 173 trials, followed by "SWOG Cancer Research Network" with 86 trials sponsored, "Children's Oncology Group" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored and "Radiation Therapy Oncology Group" with 11 trials sponsored. Other sponsors include 110 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OHSU Knight Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 249 trials as a collaborator, "Oregon Health and Science University" with 92 trials as a collaborator, "SWOG Cancer Research Network" with 18 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator and "Eastern Cooperative Oncology Group" with 12 trials as a collaborator. Other collaborators include 151 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "OHSU Knight Cancer Institute" are "Leukemia" (38 trials), "Lymphoma" (31 trials), "Breast Cancer" (29 trials), "Lung Cancer" (22 trials) and "Prostate Cancer" (19 trials). Many other conditions were trialed in "OHSU Knight Cancer Institute" in a lesser frequency.

Most popular intervention types in "OHSU Knight Cancer Institute" are "Drug" (312 trials), "Other" (116 trials), "Procedure" (113 trials), "Biological" (82 trials) and "Radiation" (66 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (42 trials), "cyclophosphamide" (34 trials), "cisplatin" (26 trials), "filgrastim" (25 trials) and "Laboratory Biomarker Analysis" (24 trials). Other intervention names were less common.

The vast majority of trials in "OHSU Knight Cancer Institute" are 342 trials for "All" genders, 41 trials for "Female" genders and 38 trials for "Male" genders.

Currently, there are 100 active trials in "OHSU Knight Cancer Institute". 9 are not yet recruiting, 56 are recruiting, 33 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 237 completed trials in OHSU Knight Cancer Institute, undefined suspended trials, and 69 terminated clinical trials to date.

Out of the total trials that were conducted in OHSU Knight Cancer Institute, 66 "Phase 1" clinical trials were conducted, 201 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 59 trials that are defined as “Not Applicable".